Dedden Dirk, Nitsche Julius, Schneider Elisabeth V, Thomsen Maren, Schwarz Daniel, Leuthner Birgitta, Grädler Ulrich
Proteros biostructures GmbH, Bunsenstraße 7a, D-82152 Planegg-Martinsried, Germany.
The Healthcare Business of Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany.
J Mol Biol. 2024 Mar 15;436(6):168483. doi: 10.1016/j.jmb.2024.168483. Epub 2024 Feb 7.
RAF protein kinases are essential effectors in the MAPK pathway and are important cancer drug targets. Structural understanding of RAF activation is so far based on cryo-electron microscopy (cryo-EM) and X-ray structures of BRAF in different conformational states as inactive or active complexes with KRAS, 14-3-3 and MEK1. In this study, we have solved the first cryo-EM structures of CRAF/14-3-3 at 3.4 Å resolution and CRAF/14-3-3/MEK1 at 4.2 Å resolution using CRAF kinase domain expressed as constitutively active Y340D/Y341D mutant in insect cells. The overall architecture of our CRAF/14-3-3 and CRAF/14-3-3/MEK1 cryo-EM structures is highly similar to corresponding BRAF structures in complex with 14-3-3 or 14-3-3/MEK1 and represent the activated dimeric RAF conformation. Our CRAF cryo-EM structures provide additional insights into structural understanding of the activated CRAF/14-3-3/MEK1 complex.
RAF蛋白激酶是丝裂原活化蛋白激酶(MAPK)信号通路中的关键效应分子,也是重要的癌症药物靶点。目前,对于RAF激活的结构理解是基于不同构象状态下BRAF的冷冻电镜(cryo-EM)结构和X射线结构,这些构象包括与KRAS、14-3-3和MEK1形成的无活性或活性复合物。在本研究中,我们利用在昆虫细胞中表达为组成型活性Y340D/Y341D突变体的CRAF激酶结构域,分别解析了分辨率为3.4 Å的CRAF/14-3-3和分辨率为4.2 Å的CRAF/14-3-3/MEK1的首个冷冻电镜结构。我们的CRAF/14-3-3和CRAF/14-3-3/MEK1冷冻电镜结构的整体架构与相应的与14-3-3或14-3-3/MEK1形成复合物的BRAF结构高度相似,代表了活化的二聚体RAF构象。我们的CRAF冷冻电镜结构为活化的CRAF/14-3-3/MEK1复合物的结构理解提供了更多见解。